These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Beta-2-microglobulin amyloidosis as a complication of peritoneal dialysis treatment. Benhamou CL; Bardin T; Noel LH; Cornelis F; Tourliere D; Maitre F; Pierre D Clin Nephrol; 1988 Dec; 30(6):346. PubMed ID: 3072139 [No Abstract] [Full Text] [Related]
9. Joint and systemic distribution of dialysis amyloid. Athanasou NA; Ayers D; Rainey AJ; Oliver DO; Duthie RB Q J Med; 1991 Mar; 78(287):205-14. PubMed ID: 2047516 [TBL] [Abstract][Full Text] [Related]
10. The role of the synovium and cartilage in the pathogenesis of beta(2)-microglobulin amyloidosis. Moe SM; Chen NX Semin Dial; 2001; 14(2):127-30. PubMed ID: 11264781 [TBL] [Abstract][Full Text] [Related]
12. Beta 2-microglobulin-related amyloidosis: where do we stand? Gejyo F; Arakawa M Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446 [No Abstract] [Full Text] [Related]
13. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient. Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922 [TBL] [Abstract][Full Text] [Related]
14. Highly sulphated glycosaminoglycans in articular cartilage and other tissues containing beta 2 microglobulin dialysis amyloid deposits. Athanasou NA; Puddle B; Sallie B Nephrol Dial Transplant; 1995; 10(9):1672-8. PubMed ID: 8559488 [TBL] [Abstract][Full Text] [Related]